- Home
- GTIM vs BOLT Comparison
GTIM vs BOLT Comparison
Compare GTIM & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTIM | BOLT |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 11.5M |
| IPO Year | 1990 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GTIM | BOLT |
|---|---|---|
| Price | $1.25 | $5.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 53.1K | 33.9K |
| Earning Date | 12-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.03 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $143,398,000.00 | $5,195,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.60 | ★ N/A |
| Revenue Growth | ★ 1.78 | N/A |
| 52 Week Low | $1.17 | $4.41 |
| 52 Week High | $2.90 | $12.60 |
Technical Indicators
Market Signals| Indicator | GTIM | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 58.45 |
| Support Level | $1.23 | $4.90 |
| Resistance Level | $1.33 | $5.45 |
| Average True Range (ATR) | 0.07 | 0.27 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 47.09 | 97.12 |
Price Performance
Historical ComparisonAbout GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.